Navigation Links
Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting
Date:6/12/2008

DENVER, June 12 /PRNewswire/ -- Cancer Clinics of Excellence (CCE), the nation's only practice-owned and physician driven network of community oncologists has announced its management slate and Board of Directors. Effective immediately, J. Ike Nicoll is President/COO of CCE. Most recently, he was the interim President of CCE. In addition, Linda Bosserman, MD, Wilshire Oncology Medical Group was named Chief Medical Officer. Dr. Bosserman had previously served as CCE's Chief Quality Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080612/AQTH094LOGO)

"Ike brings management breadth to CCE with his expertise in a wide variety of healthcare issues including administrative and claims management, drug discovery/FDA approval, clinical trials, supply chain management, payer/provider operations, provider contracting and revenue cycle management," stated CCE Chairman, Arthur "Chip" Staddon, MD. "Dr. Bosserman is a nationally renowned expert in the field of quality management, outcomes measurement and electronic medical record implementation. With Ike and Dr. Bosserman leading CCE in our business and clinical objectives, CCE is well placed to lead the most needed initiatives to improve oncology care in the United States," added Dr. Staddon.

The CCE Board of Directors is comprised of Arthur Staddon, MD, Pennsylvania Oncology; Frederick Schnell, MD, Central Georgia Cancer Care, Shahab Dadjou, CEO, Redwood Regional Medical Group; Paul Julian, EVP and Group President, McKesson Corporation and Patrick Blake, President, McKesson Specialty Care Solutions.

"The structure and breadth of the CCE Board of Directors represents the strength of our national network and the support of our strategic partner the McKesson Corporation," stated Arthur "Chip" Staddon, MD. "CCE provides our membership with a robust set of tools and resources, including our proprietary Evidence Based Treatment Protocols, to enhance our clinical efficiency and effectiveness."

These announcements were made at CCE's First Annual Membership meeting in New Orleans, LA. Over 100 clinicians attended the meeting which was created to fulfill the needs of both the clinicians and practice administrators. Clinical presentations by Frank Giles, MD, UT San Antonio; Funmi Olopade, MD, University of Chicago; Michael Fisch, MD, MD Anderson; Barbara Murphy, MD, Vanderbilt Ingram; Alan Sandler, MD, Vanderbilt Ingram; Ezekiel Emanuel, MD, National Institutes of Health; Bert O'Neil, MD, University of North Carolina; and Robert Vescio, MD, Cedars Sinai were complemented by practice management sessions on Malpractice Management, Compliance Pitfalls for Ancillary Services, New Revenue Generation and Integrating Orals into Your Practice.

About Cancer Clinics of Excellence

Cancer Clinics of Excellence is the only practice owned and physician driven network that empowers oncologists to deliver proven, evidence-based treatment in community settings while ensuring the performance of their practices. For more information, visit us at http://www.cce.us.com.


'/>"/>
SOURCE Cancer Clinics of Excellence
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Primary tumors can drive the growth of distant cancers
2. Molecular insight begins Trofex Ph. 1 trial for detection of metastatic prostate cancer
3. Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection
4. Primary Tumors Fuel Growth of Cancer Cells
5. American Idol Winner David Cook to Perform at and Jimmy Kimmel to Host Jonsson Cancer Center Foundations Taste for a Cure on June 21
6. DNA Coding May Make Bowel Prone to Cancer
7. Targeted Anticancer Drugs - In Vitro Assessment and Non-Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success
8. Cancer was one of the best things to happen to me ... but I worry about the future
9. Raloxifene Cuts Risk of Certain Type of Breast Cancer
10. Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women
11. Cancer-killing viruses influence tumor blood-vessel growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier ... position. The former overall number one pick in the 2001 NFL Draft, to the ... the record for the most career rushing yards by a quarterback (6,109) and the ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin ... of Education Research Award. The award honors scholars exemplary in their capacity to ... scholar who has demonstrated the capacity to deepen the public’s understanding and appreciation ...
(Date:4/24/2017)... Seattle, Washington (PRWEB) , ... April 24, 2017 , ... ... T-Fal OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill ... than perhaps any other marketer in the last 25 years. , Now, due to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... that they are seeking public support to bring their novel lifesaving device for ... wearable device packed with medical-grade sensors, specially designed to read a child’s vital ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
(Date:4/18/2017)... 2017 Research and Markets has announced ... Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... revenues as well as growth in the number of unit ... to market participants that design and manufacture molecular imaging equipment. ...
Breaking Medicine Technology: